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Abstract Learning how proteins fold will hardly have any impact in the way conventional — active site
centered — drugs are designed. On the other hand, this knowledge is proving instrumental in defining
a new paradigm for the identification of drugs against any target protein: folding inhibition. Targeting
folding renders drugs less prone to elicit spontaneous genetic mutations which in many cases, notably
in connection with viruses like the Human Immunodeficiency Virus (HIV), can block therapeutic action.
From the progress which has taken place during the last years in the understanding of the becoming of a
protein, and how to read from the corresponding sequences the associated three–dimensional, biologically
active, native structure, the idea of non–conventional (folding) inhibitors and thus of leads to eventual
drugs to fight disease, arguably, without creating resistance, emerges as a distinct possibility.
PACS. XX.XX.XX No PACS code given
To the question[1] “what is life?” one is forced to an-
swer that life is not one but two things[2]. Which ones ?
Replication and metabolism. The molecules of DNA and
RNA are responsible for the first function[3,4], proteins
for the second[5]. Because software (replication) is neces-
sary a parasite of hardware (proteins), the becoming of a
protein carries, to a large extent, the secret of life[6].
A possible scenario for this becoming suggests that,
starting from random polypeptide chains (i.e. chains where
the probability that a site is occupied by a given amino
acid is 1/20) containing some tens of amino acids (Fig.
1(a)), evolution rang a large number of all possible se-
quences until it clicked on a class of them containing few
(4–6) strongly hydrophobic (“hot”) amino acidsa, which
a In keeping with the fact that there are 20 different types of
amino acids, one can associate with each site of the protein a
quasispin (see e.g. [7]) of value 19/2, interpreting each projec-
tion as a given amino acid realization. In a random polymer,
each projection is equally probable for any site, and no align-
ment is observed. Lowering the evolutionary temperature [8,9]
one finds that there exists a critical temperature (equivalent to
the Curie temperature in the case of a ferromagnet and which
can be simply calculated making use of the random energy
model [10] (EC → TC), see also [11] and refs. therein) below
which one observes quasispin alignment at specific sites (hot
sites), an example of which is provided by the residue occupy-
ing site 33 (Leucine (Leu)) of the HIV–1–PR, a strongly hy-
drophobic, highly conserved amino acid which plays the role of
induced the formation and provided the varied stability
to Local Elementary Structure (LES)[11,18,19] (Fig. 1(b))
which flicker in and out the native conformation[20] (see
also App. A). The segment of the polypeptide chain as-
sociated with a LES contains approximately 10–15 amino
acids. This in keeping with the fact that segments of this
length are able to fold in milliseconds, consistent with the
fact that proteins containing about one hundred amino
acids fold in times of the order of tens of milliseconds[21].
Strongly hydrophobic, highly conserved (hot) amino
acids[22,23,24] inducing local structuring of the protein
(see App. B) are responsible to a large extent for the se-
lective interaction (molecular recognition) between a small
group (2–4) of complementary[25] (in the sense of left and
hub [12,13] (see also [14] Fig. 39 (b) and Table VI) in the native
conformation of this enzyme. Assuming that the high quasispin
projections correspond to strongly hydrophobic amino acids,
one essentially finds an alignment pointing along the (positive)
quantization axis. That is, there is a priviledged orientation in
quasispin space, and thus an associated spontaneous breaking
of amino acid content symmetry, symmetry associated with
the invariance of the Hamiltonian describing the interaction
among amino acids with respect to amino acid occupancy of
the different sites of the protein. This is similar to the spon-
taneous breaking of rotational symmetry associated with the
ferromagnetic state below the Curie temperature, symmmetry
respected by the original spin–spin Hamiltonian (see e.g. [15,
16] and [17].
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right hands) LES (one or two per chain). When this group
of LES docks, they give rise to the (postcritical) fold-
ing nucleus[26] (FN)pc (Fig. 1(c)), which inevitably grows
into a folded oligomer, that is, a unique three–dimensional
structure with incipient specific biological functions, e.g.
some amount of enzymatic activity[20]. Polymerization
(Fig. 1(d)) gives rise to typical globular proteins (or fold-
ing domains), containing 100–120 amino acids[27] (Fig.
1(e)) (see App. C).
The setting in place, by evolution, of hot amino acids[11],
that is the occupation of certain sites of the polypep-
tide chain by a single type of amino acid with probabil-
ity close to 1 (conservation) can be viewed as a spon-
taneous breaking of amino acid content (second order-
like phase transition[16] (see also [28]) corresponding to
the transition between random chains and good foldersb).
The most important emergent propertyc associated with
this, symmetry–breaking, second order–like phase transi-
tion is folding (first order phase transition; coexistence of
natived (N) and denatured (D) states, see Fig. 1(e)), a
phenomenon tantamount to biological activity and even-
tually to metabolic function and thus to the emergence of
life on earth.
LES, which can be viewed as incipient, virtual sec-
ondary structures already present with varied stability
in the denatured state, control not only folding (Fig. 2),
but also aggregation[18,31]. Because folding is much faster
than collision events between solvent exposed LES of dif-
ferent proteins belonging to each group of proteins of a
given type present in the cell (≈ 102), but much slower
than collisions between the solvent exposed LES associ-
ated with all of the 106 proteins belonging to a cell[32,33,
34], one is essentially forced to assume that evolution has
tooled the LES of each protein to recognize their comple-
mentary (like left and right hands) LES and essentially
nothing else (LES–conjecture) (see Fig. 3). This conjec-
ture is consistent, among other things, with the dearth of
folds revealed by the proteomic project[35], project aimed
at determining the native conformations of all human pro-
teins.
b Second order phase transitions are, as a rule, connected
with changes in symmetry. Consequently, the two phases
cannot coexist (e.g. aligned (ferromagnetic) and non–aligned
(paramagnetic) phases). Starting at a critical temperature, the
new phase grows continuously. This is at variance with first or-
der phase transitions (e.g. denatured→ native, taking place in
the case of the folding of proteins), where, in the thermody-
namic limit, the two phases can coexist (discontinuous changes
of the order parameter between the two phases). In particular,
at the folding temperature Tf the probabilities that the system
is in the native and in the denatured states are equal.
c That is properties not present in the Hamiltonian describ-
ing the system, neither in the “particles” (amino acids) forming
it. In the case of paramagnetic→ferromagnetic phase transition
emergent properties are, for example, domain walls, magnetic
rigidity, etc[29,30].
d Good folders (and consequently hot amino acids and LES)
lead to native states which can be viewed as scale free
networks[12,13].
To make virtual LES become real, one can intervene
the folding process with peptides displaying identical se-
quence of a LES of the protein under study[36] (Fig. 4 as
well as App. D). Such peptides, called p–LES, can bind a
complementary LES leading to misfolding and thus com-
peting with productive folding[18,37,38]. Circular dichro-
ism is consistent with such a scenario[39,40], while NMR
indicates that the only amino acids which give a signal
close to that associated with the native state of the pro-
tein are those which bind in the native state to the LES
of which the peptide p–LES is a replica[41].
This insight concerning the validity of the LES–conjecture
can be used at profit to understand aggregation, to design
novel enzymes as well as help solving the protein fold-
ing problem: for this purpose one should design all pos-
sible LES→FN→folds and establish the connection be-
tween amino acid sequence and LES (3 steps strategy,
cf. ref.[19]). Although this is a central issue in the study
of proteins, arguably, the most promising role of p–LES
is that of being leads to non–conventional (folding) in-
hibitors (Fig. 5), drugs likely not to create resistance. In
fact, the only way a target protein can avoid that a p–
LES binds to its complementary LES is by mutating the
hot amino acids of its LES. But such an event will lead
to denaturation. This does not mean that a target pro-
tein cannot develop resistance. It only means that to do
so a concerted mutation of a large number of amino acids
has to take place in a single step, an event which is very
unlikely[42]. In fact, there are no point–mutation–paths
connecting the (few) possible FN of a protein (Fig. 6; see
also [43]).
From this vantage point of view, an eventual confir-
mation of the validity of the LES–conjecture would imply
the emergence of a new paradigm in the design of drugs
and thus in the cure of diseases, in particular infectious
diseases: (high mutation barrier) folding inhibitione. Fur-
thermore, these drugs should display little side effects in
keeping with the LES–conjecture (see also Fig. 3). In the
case of the HIV–1–PR such advantage should also carry
to the low toxicity for the proteasome.
To shed light on this issue, assuming the target protein
to be an enzyme like e.g. the HIV–1–Protease, folding inhi-
bition and thus loss of activity has to be measured in vitro
(purified enzyme[39]), in acute and in chronically infected
cells (virus[44,45]), in vitro passage over long periods of
time ([46,47]) and in living organisms, that is in test an-
e “First we guess it. Then we compute the consequences of
the guess to see what would be implied if the law we guess
is right. Then we compare the results of the computation to
nature, with experiment or experience, compare it directly with
observation, to see if it works. If it disagrees with experiment
it is wrong. In that simple statement is the key to science. It
does not make any difference how beautiful your guess is. It
does not make any difference how smart you are, who made the
guess, or what your name is – if it disagrees with experiment
it is wrong. That all there is to it.” R. P. Feynman
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imals first and in AIDS patients laterf. The wonder of an
eventual positive outcome of these tests is that of helping
eradicate one by one some of the worst flagels afflicting hu-
manity. At the end, this (if it cures it is right) would be
the real outcome of the LES–conjecture, which infinitely
trascends that of Feynman (if it agrees with the experi-
ment it is, if not right at least not wrong) in spite of its
brilliancy. All the work, let alone investments, poured in
the last decade to map out the consequences and develop
embodiments of the spontaneous breaking of amino acid
symmetry content phenomenon, will be wholly justified
by the cure of even a single infected person.
Figure 1: Schematic representation of protein evolu-
tion starting from short (≈ 30 aa long) random polymers
(a) to enzymes (homodimer) (e). It is of notice that a
similar scenario is obtained by discussing protein evolu-
tion (folding domains) in terms of single, ≈ 100 amino
acid long chains. Likely, both paths were tried by nature
(within this context see App. C, as well as [51]). In draw-
ing the cartoons one had in mind the HIV–1–protease, a
dimer made out of two identical chains (homodimer) each
containing 99 amino acids (this is also true for the other
figures, note however the variance in connection with Fig.
2).
Figure 2: Schematic representation of the role played
by (weak and strong) hydrophobicity[52,53] in the folding
of a protein (see also [54] and App. B). It is of notice that
the times shown can be considered typical for 100 residue
long proteins [21], but not for the HIV–1–PR monomer,
which folds in times of the order of seconds [55].
Figure 3: LES–conjecture. The cell is crowded with
≈ 106 proteins (≈ 102 of each type) To be able to fold, LES
of one type of proteins must recognize its complementary
LES and nothing else (see App. D).
Figure 4: Schematic representation of the intervening
of a process of folding with peptides (p–LES) displaying
the same sequence as one of the LES of the target protein.
Figure 5: Schematic representation of the link existing
between LES, folding and aggregation[18], which is at the
basis of (non–conventional) folding inhibitors.
f Tests in animals (pharmacokinetics, pharmacotoxicity) and
in patients (clinical phase I and phase II and eventually III)
are very expensive, running into the millions of euros the first,
and in tens if not hundreds of millions the second. And this
kind of money can only be provided by big pharm, provided
one has deposited patent requests before publishing the results
of basic research ([48,49]). There are many ways one can in-
teract with pharmaceutical firms to have such very expensive
experiments carried out. A very attractive one (in paticular
if one has the luck to hit on a firm willing to fully support
cutting edge research without strings attached) is through an
University–pharmaceutical spin–off like Foldless S.r.l.[50].
Figure 6: Schematic representation of the two folding
nuclei[42,56] expected for the HIV–1–PR. Different colors
mean different amino acid sequence.
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Figure 1.
R.A. Broglia: A remarkable emergent property of spontaneous (amino acid content) symmetry breaking 5
Figure 2.
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Figure 3.
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Figure 4.
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Figure 5.
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Figure 6.
A Hierarchical folding
The fact that the Local Elementary Structure (LES) —
scenario (–conjecture) under different guises (foldons, fold-
ing initiation sites, nucleation centers, hydrophobic ini-
tiation sites, etc), has been discovered again and again,
testifies to its soundness and universality. In what follows,
paradigmatic examples of such, almost repetitive although
in most cases independent “eureka”–like events, spanning
half a century of research (1962–2011), are briefly dis-
cussed, starting with work done in the sixties by Anfinsen
and collaborators (see [57,58,59,20,60,61,37,62,63,64,51,
65] [66,67,68,69,70,71,72,73], and refs. therein).
Biological function appears to be more a correlate of
macromolecular geometry than of chemical detailsg,
and considerable modification of protein sequence may be
made without loss of function. Mutations and natural se-
lection are permitted with a high degree of freedom
(cold sites)[11] during accidental mutation, but a limited
number of residues (hot and warm sites)[11,18], destined
to become involved in the internal, hydrophobic core of
proteins (FN ), must be carefully conservedh, or at most
replaced with other residues which display a close chemical
and physical similarity, let alone hydrophobicity (conser-
vative mutations). Only the geometry of the protein and
its active site need be conserved, except for such residues
as actually participate in a unique way in a catalytic or
regulatory mechanism.
Because a chain of 99 amino acid residues with two
rotable bonds per residue, each bond having two or three
g Protein folding, basic physics more than detailed chemistry
h Note however ref. [74]. It is of notice that, mak-
ing use of the definition of φ–value[21], namely φ =(
∆GTS−DW −∆GTS−DM
)
/
(
∆GN−DW −∆GN−DM
)
, and of the
fact that the partial “flickering” in and out of the LES, stabi-
lized at various degrees by the hot residues, one would get for
these residues ratios displaying essentially any value, in keep-
ing with the fact that both numerator and denominator are
small.
permissible or favored orientations, would be able to as-
sume on the order of 499 to 999 different conformations in
solution, it is necessary to postulate the existence of a lim-
ited number of allowable initiating events (nucleations)
in the folding process[75], essentially controlled by hy-
drophobic forces (see App. B). This is in keeping with
the fact that in aqueous solution, ionic and hydrogen–
bonded interactions would not be expected to compete
effectively with interactions with solvent molecules and
anything less than a sizeable nucleus of interacting
amino acid side chains ((hC), (TS), (FN), (FN)pc)
i would
likely have a very short lifetimej. It seems reasonable to
suggest that portions of a protein chain that can serve as
nucleation sites for folding will be those that “flicker”
in and out of the conformation they occupy in the final
protein (complementary LES) and which, upon docking,
will form a relatively rigid structurek, stabilized by a set
of cooperative interactions. These nucleation centers, in
what has been termed their “native format”, might be
expected to involve such potentially self–dependent sub-
structures as helices, pleated sheets, or beta–bendsl.
The examples of noncovalent interaction of comple-
menting fragments[20,61] referred to in connection with
protein evolution gives strong support to the idea that, at
the basis of protein folding, there appears to exist a very
fine balance between stable, native protein structure (even
with low but much larger probability than that of random
i (hC): hydrophobic core, (TS): transition state, (FN): fold-
ing nucleus, (FN)pc: post critical (FN)
j “. . . Furthermore, it is important to stress that the amino
acid sequences of polypeptide chains designed to be the fabric
of protein molecules only make functional sense when they are
in the three–dimensional arrangement that characterizes them
in the native protein structure” (p. 228, ref. [20], third col-
umn). In this statement one finds all of what eventually became
known as inverse folding problem (and associated solution, see
refs. [8,11,18,19] and refs. therein) and as the Go¯–model[76].
On the actuality of such a statement expressed in 1973, one
can read the comment “How proteins fold” (ref. [71], published
in 2011): “Non native structure has minimal influence on the
(folding, rab) pathway. If non–native contacts are also insignif-
icant, the widespread use of Go¯–models . . . would be justified.”
(p. 465, third column). See also refs. [72] and [73].
k Using antibodies which can recognize structured segments
of staphylococcal nuclease suggests that e.g. approximately
0.02 percent (2×10−4) of fragment 99–149 exists in the native
format at any moment. Such a value, although low, is probably
very large relative to the likelihood of a peptide fragment of a
protein being found in its native format on the basis of chance
alone[20]
l Because these elements (foldons[68,51], nucleating (hy-
drophobic) pockets[60], folding initiation sites[69], transient
local structures[60], hydrophobic folding units, partially
folded kinetic intermediates, specific subdomain structures[57,
58,59,60,61,63,64,51,65,66,67,68,69,70,71,72,73], nucleation
sites[20,37,60], etc) often are intrinsically unstable, low–energy
pathways are likely to involve foldons building on top of exist-
ing structures in a process of sequential stabilization (ref. [71],
p. 465, bottom second column)
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sequences) and random, biologically meaningless polypep-
tide chains.
As an example let us refer to the fragment 1–126 of
staphylococcal nuclease molecule cited in ref. [20]. This
fragment contains all of the residues that make up the ac-
tive center of nuclease. Nevertheless, even if it represents
about 85% (≈ 126/149) of the total sequence of the nu-
clease, it exhibits only about 0.12 percent of the activity
of the native enzyme. The further addition of 23 residues
during biosynthesis, or the addition in vitro, of residues
99–149 as a complementing fragment, restores the stability
required for activity to this unfinished gene translation.
The process of folding can be shown to take place in
at least two phasesm. An initial rapid folding with a half–
time of about 50ms, and a second, somewhat slower trans-
formation with a half–time of about 200ms. The first phase
is essentially temperature–independent (on therefore pos-
sibly entropically driven,WHI) and a second temperature–
dependent (SHI)[52,53].
B Weak and strong hydrophobic interactions
From Fig. B.1, corresponding to Fig. 2 (p. 642) of ref.
[52], one can extract information concerning the Strong
Hydrophobic Interaction (SHI) (see also ref. [53]) propor-
tional to the surface (S = 4piR2) of the hydrophobic cavity
(solute)n
∆GSHIS ≈ γS = BS ,
m The first phase is essentially temperature–independent
(and therefore possibly entropically driven) the second being
temperature–dependent (see ref. [20], p. 228 first column and
beginning second one). In keeping with Kramers, the transi-
tion rate from one phase to another is given by the relation
K ∼ exp−∆ET . In the case in which there is no barrier between
the two phases ∆E → ∆Eeff = −TS and K ∼ expTST = expS .
That is, the rate K is temperature independent and thus en-
tropically driven. In other words, there are no barriers to be
overcome to find the new phase. The polypeptide chain un-
dergoes a random walk in conformation space until it clicks
on the conformation characteristic of such a phase. Assuming
contact interactions the system will acquire the needed sta-
bility to eventually undergo the second, enthalpic driven and
thus temperature dependent phase, in which the system has to
overcome a potential barrier. If, however, the force driving the
system is finite range, like e.g. the hydrophobic force, then the
clicking and stabilization on the conformation characteristic of
the first phase has to take place under the entropically driven
WHI component of this interaction (for groups of hydrophobic
residues which can fit together in a compact conformation of
radius . 1 nm, it is the volume dependent, entropic controlled
Weak Hydrophobic Interaction which stabilizes the system
(or the different groups),see App. B, in particular Fig. B.1 and
B.2.
n Dissolving a substance in a solvent can be regarded as
transforming a system from state 1 (pure solvent) to state
2 (solvent plus solute). This process is associated with a
where
B = γ ≈ 7× 10−2 J/m2 ,
is the liquid–vapour surface tensiono.
Figure B.1: Schematic representation of the numerical results
reported in ref. [52] concerning the solvation free energy
∆G = G2 −G1 for a spherical cavity in water normalized
with respect to the surface area of the circumference resulting
from the intersect of the cavity with a plane containing its
center as a function of the cavity radius (room temperature
and 1 atm of pressure). The liquid–vapour surface tension is
denoted by γ (∆G > 0 means that G2 is less negative than
G1. In other words, immersing a non–polar molecule in water
the free energy increases).
From Fig. B.1 one observes that the calculated value of
∆G/4piR2 is equal to 50 mJ/m2 for R = 0.6 nm (1 nm =
change in the free energy ∆G = G2 −G1, a quantity which is
positive for hydrophobic solutes.
o The surface tension is a measure of the force that must be
applied to surface molecules so that they experience the same
force as molecules in the interior of the liquid. Surface ten-
sion exists because of attractive forces between the molecules
in the bulk liquid (4 hydrogen–bonds in average) and the
molecules in the surface (≈ 2 hydrogen–bonds in average).
A molecule at the sur-
face experiences a net in-
ward force. This is the
reason why a mosquito
can walk on the water
surface. Surface tension
can be measured in stan-
dard experiments, by de-
stroying part of the sur-
face and recording how
much work it takes to reconstruct it (see cartoon). At ambi-
ent conditions (room temperature and 1 atm pressure) liquid
water lies close to phase coexistence with its vapour (in the fig-
ure it is shown a typical device used to learn about interaction
controlling leptodermic systems is schematically shown).
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10−9 m = 10 A˚), in the region in which ∆G coincides with
∆GWHIV . Thus
∆GWHIV
4piR2
=
∆GWHIV
V
R
3
= 50×10−3 J/m2 , (R = 0.6 nm) ,
∆GWHIV
V
=
(
3× 50
0.6 nm
× 10−3 J/m2
)
.
Then
∆GWHIV = AV ,
where
A ≈ 3× 108 J/m3 .
The crossing radius, that is the value of the radius of the
hydrophobic particle or group of particles (see Fig. 1 ref.
[52]) which marks the transition from the volume depen-
dent, entropic WHI regime, to the surface controlled, en-
thalpic SHI situation (see also Fig. B.2) is determined by
the relation
∆GWHIV (Rcross) = ∆G
SHI
S (Rcross) ,
that is
AV = BS .
Making use of the relation
V
S
=
4pi
3 R
3
4piR2
=
R
3
,
and
B
A
=
7× 10−2 J/m2
3× 108 J/m =
7
3
× 10−10 m ,
one obtains
Rcross
3
=
7
3
× 10−10 m ,
that is,
Rcross ≈ 0.7 nm .
In other words, the change of regime corresponds to a
radius of the order of 1 nm (=10 A˚). Making use of the
fact that the average Van der Waals volume of the 20
most common amino acids is ≈ 120 A˚3 (⇒ Raa(VW) ≡
Raa ≈ 3.1 A˚) and that the average range of the associated
(attractive) interaction is ≈ 0.5 A˚– 1 A˚, one expects that
the average Wigner cell radius of an amino acid is Raa ≈
4.5−5 A˚. From this estimate one obtains that the number
n
(
≈ (Rcross/Raa)3
)
of amino acids which can fit into the
largest hydrophobic cavity which immersed in water does
not deplete hydrogen bonds (WHI) is bound between the
values
(
10 A˚/4.5 A˚
)3
and
(
10 A˚/5 A˚
)3
, that is
8 . n . 11 .
It is strongly suggestive that this number is similar to that
corresponding to the number of amino acids forming LES
of typical globular proteins. This is even more so if one
takes into account the fact that hydrophobicity in con-
nection with amino acids refers principally to side chain
transfer experiments (vapour→ liquid water) ignoring the
hydrophobic parts of the backbone.
Of notice that the hydrophobic (WHI) force is likely
to lead to metastable (see also [79]), strongly fluctuating,
LES (structuring probabilities ≈ few %; within this con-
text see ref. [20]) in keeping with their size < 1 nm, and
only to sizable stabilities (SHI) of the (postcritical) FN.
C Enzymatic retention of native structural
“memory”. Protein evolution in terms of few
“short” segments
The 124–residue bovine pancreatic ribonuclease A
(RNase A) has been extensively studied, let alone chemi-
cally synthesized. It was found, among other things, that
the C–terminal peptide 111–124, the N–terminal peptide
1–20, and the central protein component 21–118 could be
mixed together non–covalently and ribonuclease activity
would be generated[20,37,61].
Other examples of retention of native structural “mem-
ory” by segments of a protein, have been found with com-
plexing fragments of the staphylococcal nuclease molecule,
a calcium–dependent, RNA– and DNA–cleaving enzyme
containing 149 amino acids and devoid of disulfide
bridges and sulphydryl groups. The protein is digested
by proteolytic enzymes. Tripsin, for example, cleaves the
staphylococcal nuclease enzyme at a number of sites. The
resulting fragments (residues 6 to 48) and (49 to 149) or
(50 to 149) are devoid of detectable structure in solution.
However, as in the case of ribonuclease S, when the frag-
ments are mixed in stoichiometric amounts, regeneration
of activity, about 10%, and of native structure character-
istics occurs[20], the complex being known as nuclease T.
D Folding inhibition
As stated in ref. [20], methods that depend on hydrody-
namic or spectral measurements are not able to detect the
presence of the flickering in and out of the native confor-
mation of the nucleation sites (virtual processes). On the
other hand, a method which can reveal such events and
which was employed in a study of the folding of staphy-
lococcal nuclease and its fragments, is based on specific
antibodies against restricted portions of the amino
acid sequencep.
p Of notice that this idea translates the sequence based strat-
egy developed in ref. [80] (see also [48]) from peptides to anti-
bodies (Eugenio Cesana, private communication). Within this
context cf. [81].
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Figure B.2: (a) Entropic, Weak Hydrophobic Interaction (WHI). Non–polar (NP) molecules of small dimension carry around
solvation shells which preserve the hydrogen bonds of bulk water, although “freezing” the solvent molecules forced to go
around the NP molecule. Assembling them together frees a number of water molecules, thus increasing entropy (∆S > 0).
This mechanism, so called weak hydrophobic interaction, is operative for values of the radius of the conglomerate . 1nm.
(b) Enthalpic, Strong Hydrophobic Interaction (SHI). Large non–polar molecules or clusters of NP molecules (R > 1nm)
represented by extended plates, impedes solvent molecules to form hydrogen bonds as in bulk water. The number of these
molecules is drastically reduced, with a net gain of enthalpy, by overlapping the two plates. (c) Of notice that at biological
conditions (room temperature and 1 atmosphere pressure), water is essentially in equilibrium with its vapour, the phase
essentially found between plates. Fluctuations are able to expel these molecules, thus reducing the internal pressure and
allowing the plates to come into contact under the pressure of the, external, water molecules. One can thus view the effect of
SHI on NP molecules as a generalized Casimir effect [77,78].
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Antibodies against specific regions of the nuclease
molecule were prepared by immunization of goats with ei-
ther polypeptide fragments of the enzyme or by infection
of the intact, native protein with subsequent fractiona-
tion of the resulting antibody in correspondence with the
protein segments of interest.
In the former manner an antibody was prepared specif-
ically directed against the polypeptide, residues 99–149,
known to exist in solution as a random chain without the
extensive helicity that characterizes this portion of the
nuclease chain when present as part of the intact enzyme.
Such an antibody preparation is referred to as anti–(99
to 149)r, the subscript indicating the, random, disordered
(denatured) state of the antigen.
A similarly specific antibody for the sequence (99 to
149) was obtained but this time by fractionation of an-
tiserum to native nuclease. While this fraction, termed
anti–(99 to 149)n exhibited a strong inhibitory effect on
the enzymatic activity of nuclease, anti–(99 to 149)r was
devoid of such an effect. In keeping with this result, the
subindex n refers to the native format of this bit of se-
quence.
Similar inhibitory effects, but this time making direct
use of polypeptides displaying identical sequence to seg-
ments of the target protein, were found in the case of the
124–residue bovine pancreatic ribonuclease A (RNase
A). The peptide His 105 – Val 124, which forms in the na-
tive conformation of the protein a β–pleated sheet, com-
pletely inhibits the refolding of this protein at a concen-
tration of 10 µM, from the reduced, denatured state at a
1:1 molar ratio of peptide to refolding protein. It has also
been observed complete inhibition of refolding by peptides
11–31 and 40–61, but this time at concentrations 100 µM
and > 100 µM respectively.
The basis for a possible explanation of these observa-
tions is the fact that, if a segment of a protein adopts
a native–like conformation as an isolated peptide, it may
inhibit protein refolding if this segment of the protein is
involved in folding in an early stage of the refolding pro-
cess. Inhibition would result from competition of the ex-
ogeneous peptide with its counterpart in the protein for
interacting with complementary regions of the refolding
protein (cf. ref. [37], see also [82]).
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